LGT Wealth India's Managing Director of International Business, Nikhil Advani, highlights how stock market investors are potentially moving out of US markets into European markets as Trump tariffs, US economic data, and fiscal imbalances create uncertainties in current market.
2 min read22 Jun 2025Some worry about stretched valuations after a big run-up.
3 min read22 Jun 2025The index has soared, regardless of considerable economic and policy risks.
3 min read21 Jun 2025Accenture share price hit an intraday low of $273.19 apiece, falling over 11% on Friday, June 20. However, Accenture shares closed the session 6.86% lower at $285.37 on NYSE.
2 min read21 Jun 2025Federal Reserve Chairman Jerome Powell used the word ‘uncertainty’ at least 14 different times during his press conference Wednesday.
3 min read20 Jun 2025The US stock market is closed today, June 19, 2025, in observance of Juneteenth, a federal holiday commemorating the end of slavery. There will be no trading in equities, options, ETFs, or bonds. Trading will resume on June 20, 2025. The market ended mixed on June 18 following the Federal Reserve's decision to maintain interest rates.
1 min read19 Jun 2025Key benchmark interest rates to ‘elevated’ economic uncertainty in the US economy — Here are 5 key highlights from the US Federal Reserve policy meeting on 18 June 2025.
4 min read19 Jun 2025US Fed Meeting LIVE: The US Fed's Federal Open Market Committee (FOMC) decided to keep the benchmark interest rates unchanged at 4.25% to 4.5% due to the diminished yet still elevated US economic uncertainty.
16 min read19 Jun 2025Lockheed Martin Share Price: Just like AVIC Chengdu — the maker of J-10 fighter jets — shares of Lockheed Martin, the company behind the F-16s prized by Pakistan, were also in focus on Wednesday, June 18, ahead of former U.S. President Donald Trump’s meeting with Pakistan Army Chief Asim Munir.
1 min read18 Jun 2025US Big Pharma firm Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion as the drugmaker focuses its investments in experimental medicine for a potential long-term growth.
2 min read17 Jun 2025